Health Technology Collaboration | Tissuepathology.com

4D Path Announces Collaboration with Daiichi Sankyo to Advance AI-Driven Predictive Biomarkers for an Antibody Drug Conjugate Program

Erica Goodpaster — Tue, 14 Apr 2026 12:11:22 +0000

4D Path and Daiichi Sankyo: Collaboration to leverage Q-Plasia OncoReader™ (QPOR™) on routine H&E slides to improve patient selection, accelerate clinical development, and deepen biological understanding of response NEWTON, Mass.–(BUSINESS WIRE)–4D Path, a company dedicated to personalizing cancer care through a novel, physics-informed approach to predicting tumor response to therapy, today announced a collaboration with Daiichi […]

The post 4D Path Announces Collaboration with Daiichi Sankyo to Advance AI-Driven Predictive Biomarkers for an Antibody Drug Conjugate Program first appeared on Tissuepathology.com.

Tribun Health CaloPix Connect: An Open API to Integrate AI into the Digital Pathology Workflow

Erica Goodpaster — Mon, 13 Apr 2026 12:24:14 +0000

From the Tribun Health blog: Discover CaloPix Connect, Tribun Health’s open API to seamlessly integrate AI into pathology workflows, without disruption or added complexity. Artificial Intelligence is rapidly transforming pathology. Automated metastasis detection, biomarker quantification, scoring assistance, therapeutic prediction—the use cases are multiplying and paving the way for faster, more precise diagnoses. Yet one major challenge […]

The post Tribun Health CaloPix Connect: An Open API to Integrate AI into the Digital Pathology Workflow first appeared on Tissuepathology.com.

PathAI and MedStar Health Announce Partnership to Deploy the AISight® Dx Digital Pathology Platform and Advanced AI Applications

Erica Goodpaster — Wed, 08 Apr 2026 13:00:10 +0000

BOSTON and COLUMBIA, Md., April 07, 2026 (GLOBE NEWSWIRE) — PathAI, a leading provider of AI-powered pathology solutions, and MedStar Health, a leading health system headquartered in Columbia, Maryland, today announced a multi-year strategic collaboration to deploy PathAI’s AISight® Dx1 Digital Pathology Platform and various AI algorithm products across the multi-site network. AISight® Dx is PathAI’s […]

The post PathAI and MedStar Health Announce Partnership to Deploy the AISight® Dx Digital Pathology Platform and Advanced AI Applications first appeared on Tissuepathology.com.

Voicebrook Announces Digital Pathology Integration with Corista, Delivering Voice-Enabled Workflow Capabilities Within the DP3 Platform

Erica Goodpaster — Tue, 07 Apr 2026 12:20:23 +0000

Voicebrook and Corista: The Voicebrook-Corista integration enables hands-free slide navigation, AI interaction, and streamlined reporting for more efficient, connected pathology workflows. Roslyn Heights, NY, March 23, 2026 –(PR.com)– Voicebrook, the leader in speech-enabled reporting and workflow automation solutions for pathology, today announced a new integration partnership with Corista, a leader in digital pathology and image management. […]

The post Voicebrook Announces Digital Pathology Integration with Corista, Delivering Voice-Enabled Workflow Capabilities Within the DP3 Platform first appeared on Tissuepathology.com.

CorePlus and Ibex Expand Partnership with Clinical Deployment of AI-Powered Diagnostics for TURP

Erica Goodpaster — Wed, 01 Apr 2026 12:30:34 +0000

CorePlus and Ibex: Digital pathology leader surpasses 250,000 AI-based analyses in routine clinical use as it incorporates Ibex Prostate for TURP to further enhance diagnostic precision. CAROLINA, Puerto Rico & BOSTON–(BUSINESS WIRE)–CorePlus Servicios Clínicos y Patológicos, LLC (CorePlus), a high-complexity CLIA-certified laboratory and global leader in digital transformation, and Ibex Medical Analytics (Ibex), a pioneer […]

The post CorePlus and Ibex Expand Partnership with Clinical Deployment of AI-Powered Diagnostics for TURP first appeared on Tissuepathology.com.

Lunit, CellCarta Announce Strategic Collaboration to Accelerate AI-Enabled Digital Pathology for Companion Diagnostic Programs

Erica Goodpaster — Mon, 30 Mar 2026 12:46:21 +0000

Lunit, CellCarta: Partnership combines Lunit’s platform-agnostic AI pathology algorithms with CellCarta’s global CDx development and laboratory execution to help biopharma teams de-risk assets and accelerate evidence generation and CDx launch pathways. SEOUL, South Korea and MONTREAL, March 30, 2026 /PRNewswire/ — Lunit (KRX: 328130), a leading provider of AI for cancer diagnostics and precision oncology, and CellCarta, a […]

The post Lunit, CellCarta Announce Strategic Collaboration to Accelerate AI-Enabled Digital Pathology for Companion Diagnostic Programs first appeared on Tissuepathology.com.